ArticleProceedings of the National Academy of Sciences of the United States of America2013

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma.

Bryan D Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.